# To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers

> **NCT06703710** · PHASE1 · RECRUITING · sponsor: **JW Pharmaceutical** · enrollment: 72 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JW2286
- **DRUG:** Placebo of JW2286

## Key facts

- **NCT ID:** NCT06703710
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-06
- **Primary completion:** 2025-11
- **Final completion:** 2026-01
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06703710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06703710, "To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06703710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*